Interstitial Cystitis (Painful Bladder Syndrome):グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Interstitial Cystitis (Painful Bladder Syndrome) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Countries Contributing to Clinical Trials in Middle East and Africa 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Interstitial Cystitis (Painful Bladder Syndrome) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Interstitial Cystitis (Painful Bladder Syndrome) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
TARIS BioMedical, Inc. 34
Clinical Trial Overview of TARIS BioMedical, Inc. 34
Urigen Pharmaceuticals, Inc. 35
Clinical Trial Overview of Urigen Pharmaceuticals, Inc. 35
Astellas Pharma Europe B.V. 36
Clinical Trial Overview of Astellas Pharma Europe B.V. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Actavis Specialty Pharmaceuticals Co. 38
Clinical Trial Overview of Actavis Specialty Pharmaceuticals Co. 38
ICStudy, LLC 39
Clinical Trial Overview of ICStudy, LLC 39
Rottapharm|Madaus 40
Clinical Trial Overview of Rottapharm|Madaus 40
Mundipharma Research GmbH & Co. KG 41
Clinical Trial Overview of Mundipharma Research GmbH & Co. KG 41
Lipella Pharmaceuticals, Inc. 42
Clinical Trial Overview of Lipella Pharmaceuticals, Inc. 42
Afferent Pharmaceuticals, Inc. 43
Clinical Trial Overview of Afferent Pharmaceuticals, Inc. 43
ICOS Corporation 44
Clinical Trial Overview of ICOS Corporation 44
Trillium Therapeutics Inc. 45
Clinical Trial Overview of Trillium Therapeutics Inc. 45
Aquinox Pharmaceuticals Inc. 46
Clinical Trial Overview of Aquinox Pharmaceuticals Inc. 46
MediciNova, Inc. 47
Clinical Trial Overview of MediciNova, Inc. 47
Taiho Pharmaceutical Co., Ltd. 48
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 48
Actavis, Inc. 49
Clinical Trial Overview of Actavis, Inc. 49
GlaxoSmithKline plc 50
Clinical Trial Overview of GlaxoSmithKline plc 50
Allergan, Inc. 51
Clinical Trial Overview of Allergan, Inc. 51
Clinical Trial Overview of Top Institutes / Government 52
William Beaumont Hospitals 52
Clinical Trial Overview of William Beaumont Hospitals 52
The National Institute of Diabetes and Digestive and Kidney Diseases 53
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 53
Assaf-Harofeh Medical Center 54
Clinical Trial Overview of Assaf-Harofeh Medical Center 54
University of Alabama at Birmingham 55
Clinical Trial Overview of University of Alabama at Birmingham 55
University Hospital Inselspital, Berne 56
Clinical Trial Overview of University Hospital Inselspital, Berne 56
The University of Iowa 57
Clinical Trial Overview of The University of Iowa 57
Beth Israel Deaconess Medical Center 58
Clinical Trial Overview of Beth Israel Deaconess Medical Center 58
The University of Tokyo 59
Clinical Trial Overview of The University of Tokyo 59
Boston Children’s Hospital 60
Clinical Trial Overview of Boston Children’s Hospital 60
Copenhagen University Hospital at Herlev 61
Clinical Trial Overview of Copenhagen University Hospital at Herlev 61
Kaunas University of Medicine 62
Clinical Trial Overview of Kaunas University of Medicine 62
Northwestern University 63
Clinical Trial Overview of Northwestern University 63
Georgetown University 64
Clinical Trial Overview of Georgetown University 64
CAMC Health System 65
Clinical Trial Overview of CAMC Health System 65
University of Washington 66
Clinical Trial Overview of University of Washington 66
Case Western Reserve University 67
Clinical Trial Overview of Case Western Reserve University 67
Capital District Health Authority, Canada 68
Clinical Trial Overview of Capital District Health Authority, Canada 68
Queen’s University 69
Clinical Trial Overview of Queen’s University 69
University of Pennsylvania 70
Clinical Trial Overview of University of Pennsylvania 70
Stanford University 71
Clinical Trial Overview of Stanford University 71
Five Key Clinical Profiles 72
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 106


【レポート販売概要】

■ タイトル:Interstitial Cystitis (Painful Bladder Syndrome):グローバル臨床試験レビューH2, 2013
■ 英文:Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月25日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162064
■ 調査対象地域:グローバル
  • 無線・モバイル端末及びOSS:ソリューション及び市場機会:Wireless/Mobile Devices and OSS: Solutions and Market Opportunities
    Wireless/Mobile Devices and OSS: Solutions and Market Opportunities is the most comprehensive research package available in the market focusing on wireless/mobile devices including OSS, User Interface (UI), device issues such as Bring Your Own Device (BYOD) and device security/privacy, user behavior and usability. This research covers all major device types including smartphones, tablets, and wear …
  • 世界のEクリニカルソリューション市場
    The introduction of e-clinical solutions to the global market was aimed at increasing the efficiency and cost effectiveness of the whole drug development process, in particular during the clinical phases. Previously, clinical testing of new drugs was a complex, lengthy and expensive process, but through e-clinical solutions, clinical data can be efficiently and securely transferred among providers …
  • OMV Petrom SA:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    OMV Petrom SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary OMV Petrom SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operati …
  • 疎水性コーティング及び表面(疎水性物質)の世界市場2016-2023
    In this report we identify the opportunities that are emerging from the latest developments in hydrophobic materials and surfaces. These include important new materials based on carbon nanotubes, graphene, nanoparticulate calcium carbonate and various nanocomposites, which are slated to create a new breed of “superhydrophobic” products. The report also covers the latest developments from more conv …
  • Tildrakizumab (Psoriasis):市場予測と分析(~2022)
    Tildrakizumab (Psoriasis) - Forecast and Market Analysis to 2022 Summary Psoriasis is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2–3% worldwide (Perera et al., 2012). Specifically, adult plaque psoriasis is the focus of this report and is defined using the 2013 International Classification of Diseases, Tenth Revision, Clinical Modification …
  • 装甲車の世界市場予測(~2023年)
    “The requirement for effective and successful defense operations is the key factor influencing the growth of the armored vehicles market across the globe.”The armored vehicles market is projected to grow from USD 14.3 billion in 2018 to USD 16.8 billion by 2023, at a CAGR of 3.25% from 2018 to 2023. Growing demand for armored vehicles due to rise in the instances of cross-border conflicts and incr …
  • 世界のモバイルサービス市場動向(2012-2016)
    TechNavio's analysts forecast the Global Mobile Services market to grow at a CAGR of 2.26 percent CAGR percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased deployment of next-generation networks. The Global Mobile Services market has also been witnessing an increased adoption of Voice over LTE (VoLTE). However, the reduced use of voice servi …
  • オンライン映画チケットサービスの世界市場2015-2019
    About Online Movie Ticketing Service Online movie ticketing service refers to booking movie tickets online using devices such as smartphones, tablets, laptops, and PCs. It is aimed at providing customers with the convenience of booking movie tickets anytime and from anywhere using the Internet. Websites and free mobile apps provided by service providers enable users to book the seats of their choi …
  • ディスポーザブル医療機器用センサーの世界市場:バイオセンサー、イメージセンサー、加速度センサー、圧力センサー、温度センサー
    The global market is estimated to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period. The disposable medical device sensors market is primarily driven by the continuously increasing healthcare expenditure, increasing incidence of healthcare acquired infections, high prevalence of diabetes and other cardiovascular diseases and growing pressure on healthcare organ …
  • 世界のオーバーザトップ(OTT)ビデオ市場
    Summary A new report by Pyramid Research, 'OTT Video Market Attractiveness Index: Worldwide Country Rankings, Market Drivers and Positioning Strategies,' examines the growth potential of OTT video services worldwide, providing insight into the opportunity to derive value from them. In order to assess the strength of the OTT video opportunity in different countries, Pyramid Research has especially …
  • 半導体液状封止材の世界市場:エポキシ樹脂、変性エポキシ樹脂
    The encapsulation technique is a process in which primarily materials such as polymers, ceramics, and metals are applied in the form of a solid or liquid on the devices. One of the major reasons for choosing the encapsulation technique for devices is the growing trend of miniaturization, where smaller and complex structures of devices need to be managed without harming the performance of the devic …
  • 2014年戦略提言:イタリアの核酸検査市場
    Highlights Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends …
  • trans-スチルベンの世界市場2015
    Trans-Stilbene (CAS 103-30-0) Market Research Report 2015 aims at providing comprehensive data on Trans-Stilbene market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Trans-Stilbene description, covers its application areas, manufacturing methods, patterns. It captures Trans-Stilbene market trends, pays close attention to Trans-Stilbene manufacturers …
  • 指紋センサの世界市場:スワイプセンサ、エリアセンサ、タッチセンサ
    The fingerprint sensors market is expected to reach USD 8.85 Billion by 2022, at a CAGR of 18.9% between 2016 and 2022. The growth of this market is propelled by government initiatives to adopt biometrics in various fields, increasing penetration of fingerprint sensors in smartphones, need for secured and simplified user access, growing adoption of mobile commerce, and increase usage of biometrics …
  • 歯科用インプラントの世界市場:チタン製インプラント、ジルコニア製インプラント
    About the Dental Implants Market A dental implant procedure helps re-establish missing teeth and comprises three primary components: the implant device, the crown or denture, and the abutment. A dental implant is manufactured using biocompatible metals, titanium, and zirconia, which offer strength, apart from having the ability to fuse with the bone. Some of the major causes of tooth loss are toot …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。